Education
About Us
Working with TipRanks
Follow Us
Thomas Mcgauley Insider Profile
4 Followers
Thomas Mcgauley, CFO at Galectin Therapeutics, holds 8.00K shares in Tenax Therapeutics (Ticker: TENX), holds 10.00K shares in Galectin Therapeutics (Ticker: GALT). Most recently, Thomas Mcgauley Bought ― shares of Tenax Therapeutics on Nov 19, 2025 for an estimated value of $58.11K.
Thomas Mcgauley has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Thomas Mcgauley holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Thomas Mcgauley
Thomas Mcgauley's Trading History
Galectin Therapeutics
May 25, 2012
CFO
Informative Buy
23.50K
$57.60K
Tenax Therapeutics
Nov 19, 2025
Interim CFO
Informative Buy
58.11K
$75.76K
List of latest transactions for each holding click on a transaction to see Thomas Mcgauley's performance on stock
You May Also Like
Thomas Mcgauley insider profile FAQ
What is the percentage of profitable transactions made by Thomas Mcgauley?
The percentage of profitable transactions made by Thomas Mcgauley is ―.
What is the average return per transaction made by Thomas Mcgauley?
The average return per transaction made by Thomas Mcgauley is ―.
What stocks does Thomas Mcgauley hold?
Thomas Mcgauley holds: GALT, TENX stocks.
What was Thomas Mcgauley’s latest transaction?
Thomas Mcgauley latest transaction was an Informative Buy of $58.11K.
What was Thomas Mcgauley's most profitable transaction?
Thomas Mcgauley’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Thomas Mcgauley's role in Galectin Therapeutics?
Thomas Mcgauley's role in Galectin Therapeutics is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.